Trial
NCT04042714
TAS-102 in Extrapulmonary Neuroendocrine Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor Research Institute
Collaborators
Taiho Oncology, Inc.
Condition
High-grade Extra Pulmonary Neuroendocrine Cancer
Intervention
All patients- TAS-102
Why stopped
Study halted due to low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-04